Characteristic | SLE patients | Healthy donors | P |
---|---|---|---|
Participants (n) | 108 | 46 | - |
Age (years) | 32.52 ± 11.97 | 32.5 ± 14.32 | 0.83 |
Sex (n; female/male) | 96/12 | 40/6 | 0.62 |
Onset age (years) | 27.14 ± 10.0 | NA | - |
Disease duration (years) | 5.4 ± 4.13 | NA | - |
SLEDAI-2K score (mean [range]) | 6 (3 to 8) | NA | - |
Mean ESR (mm/hour) | 61.58 ± 24.03 | NA | - |
Medical therapy (n) | Â | Â | Â |
   Prednisone >60 mg/day | 11 | NA | - |
   Prednisone 30 to 60 mg/day | 44 | NA | - |
   Prednisone 0 mg/day | 6 | NA | - |
   CTX | 35 | NA | - |
FIT4 relative expression | 37.84 ± 3.52 | 10.58 ± 2.64 | 0.00 |